← Open Payments lookup

CHANDLER DENSON: Open Payments

NPI 1609521418 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$716 in 29 payments from 9 companies in 2025. Trend: 2023 $1,496 · 2024 $461 · 2025 $716

Food & beverage: $716
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$181
Neurocrine BioSciences, Inc.6$150
Alkermes, Inc.6$139
E.R. Squibb & Sons, L.L.C.5$94
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$57
Vanda Pharmaceuticals Inc.1$31
Otsuka America Pharmaceutical, Inc.1$24
Axsome Therapeutics, Inc.1$23
Novo Nordisk Inc1$17

Products named: AUSTEDO XR, INGREZZA, ARISTADA, COBENFY, CAPLYTA, FANAPT, REXULTI, Sunosi.

Industry payments across AL — which companies pay providers there.